Dr Reddy’s Laboratories gets EIR for Srikakulam plant

By: |
Published: February 27, 2018 2:01:08 AM

Without going into the content of the EIR, said the USFDA has maintained official action indicated status at its plant.

DRL, Dr Reddy's Laboratories, EIR, Srikakulam plantDr Reddy’s Laboratories has received the establishment inspection report (EIR) from the drug regulator USFDA for its Srikakulam plant. (Reuters)

Dr Reddy’s Laboratories has received the establishment inspection report (EIR) from the drug regulator USFDA for its Srikakulam plant. The drug regulator has sought more details post its inspection of the plant. Without going into the content of the EIR, said the USFDA has maintained official action indicated status at its plant. “The FDA has asked us for more details. We are providing those details and continuing to engage with the FDA for resolution of pending issues,” DRL said in a filing.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Next Stories
1Sridevi’s death: From Madhuri Dixit to Karan Johar, how Bollywood biggies reacted to this shocking news
2Gujarat fair price shop owners plan indefinite strike from March 1
3BJP CMs meeting to discuss simultaneous polls, says Shivraj Singh Chouhan